• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Steven L. Chang, MD


  • Chang SL, Cipriano LE, Harshman LC, Garber AM, Chung BI.Cost-effectiveness analysis of nephron sparing options for the management of small renal masses.J Urol. 2011 May;185(5):1591-7.
  • Hsu M, Chang SL, Ferrari M, Nolley R, Presti Jr JC, Brooks JD.Length of site-specific positive surgical margins as a risk factor for biochemical recurrence following radical prostatectomy.Int J Urol. 2011 Feb 22.
  • Chang SL, Harshman LC, Presti JC.Impact of common medications on serum total prostate-specific antigen levels: analysis of the National Health and Nutrition Examination Survey.J Clin Oncol. 2010 Sep 1;28(25):3951-7.
  • Levesque BG, Cipriano LE, Chang SL, Lee KK, Owens DK, Garber AM.Cost effectiveness of alternative imaging strategies for the diagnosis of small-bowel Crohn's disease.Clin Gastroenterol Hepatol. 2010 Mar;8(3):261-7, 267.e1-4.
  • Chang SL, Freedland SJ, Terris MK, Aronson WJ, Kane CJ, Amling CL, Presti JC.Freedom from a detectable ultrasensitive prostate-specific antigen at two years after radical prostatectomy predicts a favorable clinical outcome: analysis of the SEARCH database.Urology. 2010 Feb;75(2):439-44.
  • Chang SL, Gonzalgo ML.Editorial comment.J Urol. 2010 Feb;183(2):459; discussion 459.
  • Chang SL, Gonzalgo ML.Surgery: laparoscopic prostatectomy: learning curve and cancer control.Nat Rev Urol. 2009 Jul;6(7):361-2.
  • Chang SL, Liao JC, Shinghal R.Decreasing use of luteinizing hormone-releasing hormone agonists in the United States is Independent of Reimbursement Changes: A Medicare and Veterans Health Administration claims analysis.J Urol. 2009 Jul;182(1):255-60; discussion 261.